fda glp-1 warning letters news Beyond the Headlines: to Compounders FDA Issues 30 Warning Letters

GLP-1 Medications: What You Need to Know About Side Effects Summary GLP-1 medications like Ozempic and Wegovy offer powerful benefits for weight loss and diabetes managementbut theyre not risk-free

India Demonstrates Strong Market Potential with Rising Obesity Prevalence Revenue from obesity GLP-1 treatment in India is expanding at a CAGR of 28.4%, supported by increasing obesity rates in metropolitan areas and growing awareness of cardiovascular risk factors

It can be prescribed off-label to promote weight loss in some cases

PMID: 19597519.

For these procedures, the decision to restart GLP-1 therapy should be guided by the surgical team and dietitian, typically when the patient has advanced to an appropriate diet stage and is meeting nutritional goals

coverage for weight loss is far more limited